Jun 16, 2024, 15:58
SBRT and liver transplant in previously untreated unresectable hepatocellular carcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on X:
“SBRT and liver transplant in previously untreated unresectable HCC.
SBRT may be used as a bridging treatment while waiting for deceased donor liver transplant.
PET-CT and MRI with contrast may be used for response evaluation.”
Proceed to the article.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08